Variable | CAP-B (n = 130) | CAP (n = 133) | P-value |
---|---|---|---|
Age at onset (years) | 68.6 ± 8.43 | 69.1 ± 8.27 | 0.247*a |
Site of primary tumour | Â | Â | 0.806*b |
 Caecum to transverse colon | 58 | 60 |  |
 Splenic flexure to rectum | 47 | 52 |  |
 Multiple sites | 25 | 21 |  |
Duration of treatment (mos) | 24.2 ± 18.14 | 24.7 ± 21.33 | 0.129*a |
Performance Status(ECOG) | Â | Â | 0.514*b |
 0 | 76 | 83 |  |
 1 | 54 | 50 |  |
Number of metastatic sites | Â | Â | 0.586*b |
 1 | 57 | 62 |  |
  > 1 | 43 | 40 |  |
 unknown | 30 | 31 |  |
Best response to induction treatment | Â | Â | 0.612*b |
 Stable disease | 52 | 59 |  |
 Partial response | 36 | 35 |  |
 Complete response | 11 | 13 |  |
 No change | 21 | 18 |  |
 Progression | 10 | 8 |  |
Time from induction treatment to start of maintenance treatment | Â | Â | 0.385*b |
  ≤ 1 mos | 102 | 110 |  |
  > 1 mos | 28 | 23 |  |
Primary site | Â | Â | 0.639*b |
 Colon | 52 | 57 |  |
 Rectum | 78 | 76 |  |